CD276 and esophageal squamous cell carcinoma: Furthermore, in esophageal squamous cell carcinoma (ESCC), investigators found that B7-H3 glycosylation, particularly fucosylation, is significantly upregulated, promoting the development and progression of ESCC and suggesting that B7-H3 fucosylation may serve as a potential biomarker for this cancer [205].